BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29146595)

  • 1. The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation.
    Lau D; Elezagic D; Hermes G; Mörgelin M; Wohl AP; Koch M; Hartmann U; Höllriegl S; Wagener R; Paulsson M; Streichert T; Klatt AR
    J Biol Chem; 2018 Jan; 293(1):203-214. PubMed ID: 29146595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides derived from the cartilage.-specific C-type Lectin Domain Family 3 Member A (CLEC3A) - potential in the prevention and treatment of septic arthritis.
    Elezagic D; Mörgelin M; Hermes G; Hamprecht A; Sengle G; Lau D; Höllriegl S; Wagener R; Paulsson M; Streichert T; Klatt AR
    Osteoarthritis Cartilage; 2019 Oct; 27(10):1564-1573. PubMed ID: 31279936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity.
    Tsunezumi J; Higashi S; Miyazaki K
    J Cell Biochem; 2009 Mar; 106(4):693-702. PubMed ID: 19173304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator.
    Westergaard UB; Andersen MH; Heegaard CW; Fedosov SN; Petersen TE
    Eur J Biochem; 2003 Apr; 270(8):1850-4. PubMed ID: 12694198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
    Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
    J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an alpha-helical coiled coil.
    Nielsen BB; Kastrup JS; Rasmussen H; Holtet TL; Graversen JH; Etzerodt M; Thøgersen HC; Larsen IK
    FEBS Lett; 1997 Jul; 412(2):388-96. PubMed ID: 9256258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography.
    Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J
    Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein.
    Fuhlendorff J; Clemmensen I; Magnusson S
    Biochemistry; 1987 Oct; 26(21):6757-64. PubMed ID: 3427041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development.
    Klatt AR; Nitsche DP; Kobbe B; Mörgelin M; Paulsson M; Wagener R
    J Biol Chem; 2000 Feb; 275(6):3999-4006. PubMed ID: 10660556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of antibodies against extracellular matrix proteins in human osteoarthritis.
    Ruthard J; Hermes G; Hartmann U; Sengle G; Pongratz G; Ostendorf B; Schneider M; Höllriegl S; Zaucke F; Wagener R; Streichert T; Klatt AR
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1273-1277. PubMed ID: 30001809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cartilage-derived, C-type lectin (CLECSF1): structure of the gene and chromosomal location.
    Neame PJ; Tapp H; Grimm DR
    Biochim Biophys Acta; 1999 Sep; 1446(3):193-202. PubMed ID: 10524194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4).
    Razzaq TM; Bass R; Vines DJ; Werner F; Whawell SA; Ellis V
    J Biol Chem; 2003 Oct; 278(43):42679-85. PubMed ID: 12913003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
    Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
    J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
    Byeon IJ; Kelley RF; Mulkerrin MG; An SS; Llinás M
    Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.